First American Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

First American Trust's VRTX Position: Q2 2026 in Review

First American Trust reduced its Vertex Pharmaceuticals (VRTX) stake by 6.1% in Q2 2026, selling an estimated $12.4K and leaving 430 shares worth $214K. The position accounts for 0.01% of the portfolio, ranked #281.

First American Trust first reported a position in VRTX in Q2 2022 and has held it in 17 quarters since. The position peaked at $8.81M in Q2 2024. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

• First American Trust held 430 shares of Vertex Pharmaceuticals worth $214K as of Q2 2026.
• First American Trust sold 28 Vertex Pharmaceuticals shares in Q2 2026, an estimated $12.4K.
• Vertex Pharmaceuticals made up 0.01% of First American Trust's portfolio in Q2 2026, its #281 holding.
• First American Trust first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
• First American Trust's Vertex Pharmaceuticals position peaked at $8.81M in Q2 2024.
• 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on First American Trust's 13F filing for Q2 2026, filed 10 Aug 2026.